Increase of complement fragment C5a in cerebrospinal fluid during exacerbation of neuromyelitis optica.
about
The Immunology of Neuromyelitis Optica-Current Knowledge, Clinical Implications, Controversies and Future PerspectivesClinical spectrum and treatment of neuromyelitis optica spectrum disorders: evolution and current status.Neuromyelitis optica: clinical features, immunopathogenesis and treatment.Comparison of clinical characteristics between neuromyelitis optica spectrum disorders with and without spinal cord atrophy.Variable sensitivity to complement-dependent cytotoxicity in murine models of neuromyelitis optica.Involvement of antibody-dependent cell-mediated cytotoxicity in inflammatory demyelination in a mouse model of neuromyelitis optica.C1q-targeted monoclonal antibody prevents complement-dependent cytotoxicity and neuropathology in in vitro and mouse models of neuromyelitis optica.B cells in MS and NMO: pathogenesis and therapy.Therapeutic options in neuromyelitis optica spectrum disorders.Plasma complement biomarkers distinguish multiple sclerosis and neuromyelitis optica spectrum disorder.Neuromyelitis optica study model based on chronic infusion of autoantibodies in rat cerebrospinal fluid.
P2860
Q26767391-0956812A-8B8D-47E5-AE7A-2784645239EAQ30676331-64C76648-239D-41F7-8AD0-DCBB1BE63EE0Q30785267-06614D52-74ED-48A5-8D80-5FFF8A4C281CQ34996129-EA4693AB-810D-4E51-91A5-5565C65CDF0BQ37466478-F93CD73B-9B16-4DD9-B052-606EB798B271Q37472990-43044181-F345-4F68-A928-D609545DAFB1Q37615906-9D629199-7DE4-4B59-8351-90EB999A12E9Q38212081-371F351C-FEBB-4EEA-9735-6F93F8E6A667Q38721559-6EEE87CF-0704-4EF3-A116-3C02CA9A3D2EQ40545113-99E391CB-D328-4113-9A42-504797D27239Q41831300-68EB2322-5D74-45A9-84FB-3FEE3CC92F88
P2860
Increase of complement fragment C5a in cerebrospinal fluid during exacerbation of neuromyelitis optica.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Increase of complement fragmen ...... ation of neuromyelitis optica.
@en
Increase of complement fragmen ...... ation of neuromyelitis optica.
@nl
type
label
Increase of complement fragmen ...... ation of neuromyelitis optica.
@en
Increase of complement fragmen ...... ation of neuromyelitis optica.
@nl
prefLabel
Increase of complement fragmen ...... ation of neuromyelitis optica.
@en
Increase of complement fragmen ...... ation of neuromyelitis optica.
@nl
P2093
P1476
Increase of complement fragmen ...... ation of neuromyelitis optica.
@en
P2093
Hiroshi Kuroda
Kazuo Fujihara
Masashi Aoki
Rina Takano
Shigeru Sato
Tatsuro Misu
Toshiyuki Takahashi
Yasuto Itoyama
Yoshiki Takai
P304
P356
10.1016/J.JNEUROIM.2012.09.002
P577
2012-09-25T00:00:00Z